David O Reilly (@DavidOReilly2) header
David O Reilly (@DavidOReilly2) profile picture

Medical Oncologist, Clinical Research Fellow @ Beaumont RCSI Cancer Centre

Dublin, Ireland
Joined April 2011
Photo by David O Reilly (@DavidOReilly2)Photo by David O Reilly (@DavidOReilly2)Photo by David O Reilly (@DavidOReilly2)Photo by David O Reilly (@DavidOReilly2)Photo by David O Reilly (@DavidOReilly2)Photo by David O Reilly (@DavidOReilly2)Photo by David O Reilly (@DavidOReilly2)Photo by David O Reilly (@DavidOReilly2)Photo by David O Reilly (@DavidOReilly2)Photo by David O Reilly (@DavidOReilly2)
David O Reilly retweeted
Received some incredibly difficult news. Histology from my brain surgery confirmed my tumour is a malignant, terminal grade 4 glioblastoma. Moving forward with chemo/radiotherapy to buy time, but focus is on quality of life. Devastated. Please hold your loved ones tight. ❤️
354
98
10
4,364
164,611
Congratulations to all - especially to Irish representatives @HennessyMaeve and @rachelkeogh...delighted for you
We're thrilled to officially announce the 2026 class of Conquer Cancer Grants and Awards recipients! 🔬 These grants empower the next generation of physician-scientists to turn innovative ideas into clinical breakthroughs. Congratulations to the new class—see you in Chicago for #ASCO26! Full list of recipients here: bit.ly/4x0qpBF #ResearchConquersCancer #ConquerCancer @ASCO
1
13
294
Congratulations to Dr @OanaDeac , NCRI intern, Oncology Specialist Registrar and ICAT Fellow , on her open‑access publication on young‑onset GI cancer. 🔬 Linking clinical expertise with population cancer data for real‑world insights. 🔗 authors.elsevier.com/sd/arti…
1
5
2
16
3,220
David O Reilly retweeted
Delighted to see our data on 1st line zongertinib in HER2 TKD mutant NSCLC pts with and without CNS mets (BEAMION-Lung01), now in @NEJM. Now FDA approved 1st line. Hoping for @MHRAgovuk & @NICEComms approvals to follow! @royalmarsdenNHS @ICR_London
In a phase 1 trial of first-line zongertinib for HER2-mutated non–small-cell lung cancer, an objective response occurred in 76% of patients, with a median progression-free survival of 14.4 months. Full Beamion LUNG-1 trial results: nejm.org/doi/full/10.1056/NE… Editorial: EGFR’s Poor Sibling nejm.org/doi/full/10.1056/NE…
6
28
3
90
12,092
Super interesting KRAS session - congrats @DrJNaidoo @DocSacher KANDELELIT-001: Striking activity in PDL1>50% with RR of 87% ADEPPT: Durable responses seen in subset of patients @etop_ibcsg @CancerCentreIre @cancertrials_ie
6
133
Congrats @gwalls89 highlighting need to consider competing CV risks for patients with NSCLC #elcc #lcsm @myESMO
6
128
Congrats @mraheelhashim and @FordePatrick. Thought provoking study - expect to see lots of studies more like this soon!
🚨🚨 Hot off the press How Much Is Enough? Ultra-Low Doses of Immunotherapy to Improve Access and Affordability @JCO_ASCO editorial on IO dosing In view of recent debate regarding ultra low doses of Nivolumab ascopubs.org/doi/10.1200/JCO…
5
160
Congratulations @CanResUCC for this exciting time for the South of Ireland @RoisinMConnolly @jgleesonirl @Seamusoreilly18 @Dcollinsflynn
Inspiring day @CanResUCC @UCC World Cancer Day Event. Super lineup outlining cancer trial innovations - Liquid biopsy @DrSanjayPopat - Investigator-led trials @jgleesonirl - Working with @cancertrials_ie @gerryhanna Congrats @RoisinMConnolly on a dynamic & ambitious vision
6
207
Big thanks to supervisors, examiners and chair and many more for all their help getting this far! @DrJNaidoo @sinead_toomey Bryan Hennessy, Judith Coppinger @DrSanjayPopat @MariOzaki14 @RCSI_Irl @CancerCentreIre
Huge congratulations to Dr @DavidOReilly2 who successfully defended his PhD thesis this morning. Thanks to Prof @DrSanjayPopat and Prof Judith Coppinger for examining, Dr @MariOzaki14 for chairing and @RCSI_postgrad for all the support
5
20
325
Very proud of Prof. @DrJNaidoo ! Idly reading emails from week & came across below from Hopkins where she is adjunct faculty. Not a surprise but she is one of the most highly cited scientists worldwide & we are lucky she is leading lung cancer research @RCSI_Irl @CancerCentreIre
1
10
293
Implementation of the SIPS surgical handover system was associated with improvements in handover quality, patient physiology, and staff perceptions of safety without prolonging handover meetings. ja.ma/4gUFL2O
4
2
6
1,485
Honored to present our data on neoadjuvant nivolumab and nivolumab/ipilimumab in potentially resectable diffuse pleural mesothelioma (DPM) at #WCLC25. @IASLC We evaluated perioperative nivo and nivo/ipi in epithelioid or biphasic DPM deemed resectable by multi-D assessment. 1/7
10
25
3
81
16,124
David O Reilly retweeted
#TeamIrelandWCLC25☘️ Ireland’s lung cancer team at #WCLC25 — nurses, surgeons, oncologists, scientists & advocates, working for patients @IASLC @CancerCentreIre @CancerInstIRE @UL @CanResUCC @svuh @MaterCancer @uniofgalway @QUBelfast @TUH_Tallaght @LungCommunity @IrishCancerSoc
14
52
3,135
Lots of interest in how to incorporate EBC into liquid biopsy translational and clinical pathways. Thanks @IASLC for oppurtunity to present! @IrishCancerSoc @CancerCentreIre @CancerInstIRE @DrJNaidoo @sinead_toomey @RCSI_Irl @Drogheda_Oncol
1
7
25
1,109
Such an important patient-centered talk from Ornagh reminding us of the most important things. Congrats Ornagh! @CancerCentreIre @IASLC @DrJNaidoo @LungCommunity #WCLC25
2
15
1,108
Congrats to poster presenters today! - Survival outcomes in female never smokers with NSCLC @zaccoyne - T Cell charecteristics in early stage NSCLC @laurastaunton -Radiation oncology clinical trial eligibility in real world cohort @gwalls89
2
7
23
1,141
Congratulations @DrJNaidoo ! How lucky we are to have an Irish co-chair of the world lung cancer conference #WCLC25 @cancertrials_ie @CancerCentreIre
Great #WCLC25 opening Ceremony with the amazing chairs @UmbertoMalapel1 @DrJNaidoo @NReguart @IsaOpitz !! Congrats on the success of this excellent meeting! @IASLC
2
29
1,337